Dr B raises $8m for telehealth service to deliver COVID antivirals
pharmaphorum
AUGUST 19, 2022
It will provide a low-cost online consultation and prescription medicine service to patients, starting with the two oral COVID-19 antivirals – Pfizer’s Paxlovid (nirmatrelvir/ritonavir) and Merck & Co’s Lagevrio (molnupiravir) – which are authorised for at-home use by the FDA.
Let's personalize your content